Arteriosclerosis and Thrombosis, Vol 11, 23-31, Copyright © 1991 by American Heart Association

ARTICLES

Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon (Papio sp.)

RS Kushwaha, DS Lewis, KD Carey and HC McGill Jr
Department of Physiology and Medicine, Southwest Foundation for Biomedical Research, San Antonio, TX 78228-0147.

We determined the effect of estrogen and progesterone on plasma cholesterol and lipoprotein cholesterol concentrations and on arterial lesions in 24 ovariectomized and hysterectomized baboons fed a high- cholesterol/high-saturated-fat diet. These baboons were divided into four groups: untreated control (C); estrogen, 100 micrograms/kg/week injected i.m. (E); progesterone, 3 mg/kg/day (P); and estrogen plus progesterone (E + P). The treatment regimen continued for 18 months. Cholesterol levels in plasma and lipoproteins were measured before hormone treatment and at 3, 10, and 18 months of treatment. Postheparin plasma lipoprotein lipase (LPL) activity was also measured during the treatment. After 18 months of hormone treatment, baboons were necropsied and arterial lesions were measured. Hormone treatment significantly influenced plasma cholesterol (P greater than C greater than [E + P] greater than E) and very low density lipoprotein plus low density lipoprotein (VLDL + LDL) cholesterol (P greater than C greater than [E + P] greater than E), with very little effect on high density lipoprotein (HDL) cholesterol concentration. The E + P group had a significantly higher HDL cholesterol concentration than did the P group. The (VLDL + LDL)/HDL cholesterol ratios in the E and E + P groups were significantly lower than those in the P and C groups. LPL activities were significantly lower in the E group compared with those in the E + P and P groups. Hormone treatment significantly influenced lesions in four (innominate, carotid, iliac, and abdominal aorta) of seven arteries. The P group had the most fatty streaks, and the E + P group had the least.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				K. N. Hewitt, W. C. Boon, Y. Murata, M. E. E. Jones, and E. R. Simpson The Aromatase Knockout Mouse Presents with a Sexually Dimorphic Disruption to Cholesterol Homeostasis Endocrinology, September 1, 2003; 144(9): 3895 - 3903. [Abstract] [Full Text] [PDF]

				F. L. Bellino and P. M. Wise Nonhuman Primate Models of Menopause Workshop Biol Reprod, January 1, 2003; 68(1): 10 - 18. [Abstract] [Full Text] [PDF]

				D. Lopez, M. D. Sanchez, W. Shea-Eaton, and M. P. McLean Estrogen Activates the High-Density Lipoprotein Receptor Gene via Binding to Estrogen Response Elements and Interaction with Sterol Regulatory Element Binding Protein-1A Endocrinology, June 1, 2002; 143(6): 2155 - 2168. [Abstract] [Full Text] [PDF]

				M. Fischer, A. Baessler, and H. Schunkert Renin angiotensin system and gender differences in the cardiovascular system Cardiovasc Res, February 15, 2002; 53(3): 672 - 677. [Abstract] [Full Text] [PDF]

				H. N. Hodis, W. J. Mack, R. A. Lobo, D. Shoupe, A. Sevanian, P. R. Mahrer, R. H. Selzer, C.-r. Liu, C.-h. Liu, S. P. Azen, et al. Estrogen in the Prevention of Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial Ann Intern Med, December 4, 2001; 135(11): 939 - 953. [Abstract] [Full Text] [PDF]

				M. Otsuki, H. Saito, X. Xu, S. Sumitani, H. Kouhara, T. Kishimoto, and S. Kasayama Progesterone, but Not Medroxyprogesterone, Inhibits Vascular Cell Adhesion Molecule-1 Expression in Human Vascular Endothelial Cells Arterioscler Thromb Vasc Biol, February 1, 2001; 21(2): 243 - 248. [Abstract] [Full Text] [PDF]

				I. C. D. Westendorp, B. A. in't Veld, D. E. Grobbee, H. A. P. Pols, W. T. Meijer, A. Hofman, and J. C. M. Witteman Hormone Replacement Therapy and Peripheral Arterial Disease: The Rotterdam Study Arch Intern Med, September 11, 2000; 160(16): 2498 - 2502. [Abstract] [Full Text]

				I. C. D. Westendorp, B. A. I.’t Veld, M. L. Bots, J. M. Akkerhuis, A. Hofman, D. E. Grobbee, and J. C. M. Witteman Hormone Replacement Therapy and Intima-Media Thickness of the Common Carotid Artery : The Rotterdam Study Stroke, December 1, 1999; 30(12): 2562 - 2567. [Abstract] [Full Text] [PDF]

				P. J. Garry, R. N. Baumgartner, S. G. Brodie, G. D. Montoya, H. C. Liang, R. D. Lindeman, and T. M. Williams Estrogen Replacement Therapy, Serum Lipids, and Polymorphism of the Apolipoprotein E Gene Clin. Chem., August 1, 1999; 45(8): 1214 - 1223. [Abstract] [Full Text] [PDF]

				B. P. McGrath, Y.-L. Liang, H. Teede, L. M. Shiel, J. D. Cameron, and A. Dart Age-Related Deterioration in Arterial Structure and Function in Postmenopausal Women : Impact of Hormone Replacement Therapy Arterioscler Thromb Vasc Biol, July 1, 1998; 18(7): 1149 - 1156. [Abstract] [Full Text] [PDF]

				P. Alexandersen, J. Haarbo, I. Sandholdt, M. Shalmi, H. Lawaetz, and C. Christiansen Norethindrone Acetate Enhances the Antiatherogenic Effect of 17ß-Estradiol : A Secondary Prevention Study of Aortic Atherosclerosis in Ovariectomized Cholesterol-Fed Rabbits Arterioscler Thromb Vasc Biol, June 1, 1998; 18(6): 902 - 907. [Abstract] [Full Text] [PDF]

				C. H. Selzman, T. A. Whitehill, B. D. Shames, E. J. Pulido, B. C. Cain, and A. H. Harken The Biology of Estrogen-Mediated Repair of Cardiovascular Injury Ann. Thorac. Surg., March 1, 1998; 65(3): 868 - 874. [Abstract] [Full Text] [PDF]

				D. C. Schwenke Gender Differences in Intima-Media Permeability to Low-Density Lipoprotein at Atherosclerosis-Prone Aortic Sites in Rabbits : Lack of Effect of 17ß-Estradiol Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2150 - 2157. [Abstract] [Full Text]

				N. H. Bjarnason, J. Haarbo, I. Byrjalsen, R. F. Kauffman, and C. Christiansen Raloxifene Inhibits Aortic Accumulation of Cholesterol in Ovariectomized, Cholesterol-Fed Rabbits Circulation, September 16, 1997; 96(6): 1964 - 1969. [Abstract] [Full Text]

				S. R.W. St Clair Effect of 17ß-Estradiol on Metabolism of Acetylated Low-Density Lipoprotein by THP-1 Macrophages in Culture Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1691 - 1700. [Abstract] [Full Text]

				K. Krasinski, I. Spyridopoulos, T. Asahara, R. van der Zee, J. M. Isner, and D. W. Losordo Estradiol Accelerates Functional Endothelial Recovery After Arterial Injury Circulation, April 1, 1997; 95(7): 1768 - 1772. [Abstract] [Full Text]

				I. Spyridopoulos, A. B. Sullivan, M. Kearney, J. M. Isner, and D. W. Losordo Estrogen-Receptor–Mediated Inhibition of Human Endothelial Cell Apoptosis : Estradiol as a Survival Factor Circulation, March 18, 1997; 95(6): 1505 - 1514. [Abstract] [Full Text]

				B. Imthurn, M. Rosselli, A. W. Jaeger, P. J. Keller, and R. K. Dubey Differential Effects of Hormone-Replacement Therapy on Endogenous Nitric Oxide (Nitrite/Nitrate) Levels in Postmenopausal Women Substituted with 17{beta}-Estradiol Valerate and Cyproterone Acetate or Medroxyprogesterone Acetate J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 388 - 394. [Abstract] [Full Text] [PDF]

				R. L. Levine, S.-J. Chen, J. Durand, Y.-F. Chen, and S. Oparil Medroxyprogesterone Attenuates Estrogen-Mediated Inhibition of Neointima Formation After Balloon Injury of the Rat Carotid Artery Circulation, November 1, 1996; 94(9): 2221 - 2227. [Abstract] [Full Text]

				R. S. Kushwaha, B. Guntupalli, E. M. Jackson, and H. C. McGill Jr Effect of Estrogen and Progesterone on the Expression of Hepatic and Extrahepatic Sterol 27-Hydroxylase in Baboons (Papio sp) Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 1088 - 1094. [Abstract] [Full Text]

				M. Rosselli, B. Imthurn, P. J. Keller, E. K. Jackson, and R. K. Dubey Circulating Nitric Oxide (Nitrite/Nitrate) Levels in Postmenopausal Women Substituted With 17ß-Estradiol and Norethisterone Acetate : A Two-Year Follow-up Study Hypertension, April 1, 1995; 25(4): 848 - 853. [Abstract] [Full Text]